A Phase I Study of Pyrimethamine in Patients With GM2 Gangliosidosis

NCT00679744 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Due to lack of funding

Conditions

G(M2) Ganglioside
Tay-Sachs Disease Ganglioside
Sandhoff Disease Ganglioside

Interventions

DRUG: Pyrimethamine

Sponsor

Exsar Corporation

Collaborators

[object Object]
[object Object]
[object Object]